Search Results - "O'DWYER, M. E"

Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective by La Rosée, P, O'Dwyer, M E, Druker, B J

“…Clinical phase I/II studies with the Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec, formerly STI571) for the treatment for chronic myelogenous…”
Get full text

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix by Glavey, S V, Naba, A, Manier, S, Clauser, K, Tahri, S, Park, J, Reagan, M R, Moschetta, M, Mishima, Y, Gambella, M, Rocci, A, Sacco, A, O'Dwyer, M E, Asara, J M, Palumbo, A, Roccaro, A M, Hynes, R O, Ghobrial, I M

“…The extracellular matrix (ECM) is a major component of the tumor microenvironment, contributing to the regulation of cell survival, proliferation,…”
Get full text

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate by O'Dwyer, M E, Gatter, K M, Loriaux, M, Druker, B J, Olson, S B, Magenis, R E, Lawce, H, Mauro, M J, Maziarz, R T, Braziel, R M

“…Imatinib mesylate, an Abl-specific kinase inhibitor, produces sustained complete hematologic responses (CHR) and major cytogenetic responses (MCR) in chronic…”
Get full text

Dental anomalies in Axenfeld–Rieger syndrome by O'DWYER, E. M., JONES, D. C.

“…The authors describe the case of a 10‐year‐old girl presenting with Axenfeld–Rieger syndrome (ARS), a rare autosomal dominant condition. The patient showed…”
Get full text

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271 by Natoni, A, Smith, T A G, Keane, N, McEllistrim, C, Connolly, C, Jha, A, Andrulis, M, Ellert, E, Raab, M S, Glavey, S V, Kirkham-McCarthy, L, Kumar, S K, Locatelli-Hoops, S C, Oliva, I, Fogler, W E, Magnani, J L, O'Dwyer, M E

“…Multiple myeloma (MM) is characterized by the clonal expansion and metastatic spread of malignant plasma cells to multiple sites in the bone marrow (BM)…”
Get full text

Pyodermatitis-pyostomatitis vegetans complicated by methicillin-resistant Staphylococcus aureus infection by Konstantopoulou, M., O'Dwyer, E. M., Steele, J. C., Field, E. A., Lewis, M. A. O., Macfarlane, A. W.

“…Summary Pyodermatitis–pyostomatitis vegetans (PPV), a rare disorder of the skin and oral mucosa, is considered a highly specific marker for inflammatory bowel…”
Get full text

An alternative use for rigid external distractors by O’Dwyer, E.M., Askar, W., Blackburn, T.K., Richardson, D.

Get full text

Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia by O’Dwyer, Michael E, Druker, Brian J

“…The bcr-abl fusion protein is present in the vast majority of cases of chronic myelogenous leukemia, and the deregulated tyrosine kinase activity of this…”
Get full text

Successful Treatment of Aggressive Post Transplant Lymphoproliferative Disorder using Rituximab by O'dwyer, Michael E., Launder, Teresa, Rabkin, John M., Nichols, Craig R.

“…A 52 year-old female developed a histologically aggressive, Epstein-Barr virus positive, lymphoproliferative disorder involving the brain and liver 4 months…”
Get full text

Post-menopausal cyclic eruptions: autoimmune progesterone dermatitis by Bolaji, I I, O'Dwyer, E M

“…Two cases of autoimmune progesterone dermatitis (AIPD) are reported. The patients developed a recurrent eruption, primarily on the extremities after receiving…”
Get more information

Circulating lymphocyte subpopulations in pregnancy: a longitudinal study by Tallon, DF, Corcoran, DJ, O'Dwyer, EM, Greally, JF

“…Peripheral blood lymphocyte subpopulations were studied sequentially during the gestation and the postpartum period of 84 obstetrically normal women. Both the…”
Get full text

Chronic myelogenous leukaemia – new therapeutic principles by O'Dwyer, Michael E., Druker, Brian J.

“…O’Dwyer ME, Druker BJ (Oregon Health Sciences University, Portland, USA). Chronic myelogenous leukaemia – new therapeutic principles. J. Intern Med 2001; 250:…”
Get full text

Direct solid-phase enzyme immunoassay of progesterone in saliva by Tallon, D F, Gosling, J P, Buckley, P M, Dooley, M M, Cleere, W F, O'Dwyer, E M, Fottrell, P F

“…We have developed a rapid enzyme immunoassay for progesterone in saliva. This solid-phase assay is carried out on microtitre plates with no extraction or…”
Get more information

ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia : validating the promise of molecularly targeted therapy by MAURO, Michael J, O'DWYER, Michael E, DRUKER, Brian J

“…The deregulated tyrosine kinase activity of the Bcr-Abl fusion protein has been established as the causative molecular event in chronic myelogenous leukemia…”
Get full text

The return of postpartum fertility monitored by enzyme-immunoassay for salivary progesterone by Bolaji, I I, Tallon, D F, Meehan, F P, O'Dwyer, E M, Fottrell, P F

“…A longitudinal study in which daily salivary progesterone and estrone were measured by solid-phase enzyme-immunoassays was performed in 30 postpartum women to…”
Get more information

Enzyme immunoassay of progesterone in saliva by Tallon, D F, O'Dwyer, E M, Fottrell, P F

Get full text

Pulmonary hemorrhage in a hemophiliac simulating a lung neoplasm by O'Dwyer, Michael E., DeLoughery, Thomas G.

“…We report an elderly, male smoker with moderate hemophilia B who presented with hemoptysis. Chest imaging revealed a well‐circumscribed, pulmonary, mass…”
Get full text

Elevated levels of endometrial lactate dehydrogenase in hyperplasia and carcinoma of human endometrium by Fottrell, P F, Spellman, C M, O'Dwyer, E M

Get full text

Buccal Oxytocin by O'Dwyer, E. M., Gate, J. M.

Get full text

Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters by Bolaji, I I, Grimes, H, Mortimer, G, Tallon, D F, Fottrell, P F, O'Dwyer, E M

“…Cardiovascular disease among older women is a major health problem and is the leading cause of death in this group in developed countries. The risk is reduced…”
Get more information